AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity

AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity

Inflammasomes are critical sensors that convey cellular stress and pathogen presence to the immune system by activating inflammatory caspases and cytokines such as IL-1β. The nature of endogenous stress signals that activate inflammasomes remains unclear. Here we show that an inhibitor of the HIV as...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Di Micco, A, Frera, G, Lugrin, J, Jamilloux, Y, Hsu, E, Tardivel, A, De Gassart, A, Zaffalon, L, Bujisic, B, Siegert, S, Quadroni, M, Broz, P, Henry, T, Hrycyna, C, Martinon, F
Format:	Journal article
Język:	English
Wydane:	National Academy of Sciences 2016

Podobne zapisy

Taking AIM at Influenza: The Role of the AIM2 Inflammasome
od: Dianne W. Xu, i wsp.
Wydane: (2024-09-01)

The aspartyl protease DDI2 drives adaptation to proteasome inhibition in multiple myeloma
od: Mélanie Op, i wsp.
Wydane: (2022-05-01)

The Role of AIM2 Inflammasome in Knee Osteoarthritis
od: Yang J, i wsp.
Wydane: (2022-11-01)

Roles of AIM2 Gene and AIM2 Inflammasome in the Pathogenesis and Treatment of Psoriasis
od: Jieyi Wang, i wsp.
Wydane: (2022-09-01)

Inflammasomes in Host Defense and Autoimmunity
od: Petr Broz
Wydane: (2016-12-01)

Activation and Pharmacological Regulation of Inflammasomes
od: Chen Chen, i wsp.
Wydane: (2022-07-01)

Detection of ASC Oligomerization by Western Blotting
od: Jérôme Lugrin, i wsp.
Wydane: (2017-05-01)

The protease DDI2 regulates NRF1 activation in response to cadmium toxicity
od: Sérgio T. Ribeiro, i wsp.
Wydane: (2022-10-01)

The AIM2 inflammasome is activated in astrocytes during the late phase of EAE
od: William E. Barclay, i wsp.
Wydane: (2022-04-01)

Role of the AIM2 Inflammasome in Cancer: Potential Therapeutic Strategies
od: Chiara Colarusso, i wsp.
Wydane: (2025-02-01)

Mitochondrial ROS potentiates indirect activation of the AIM2 inflammasome
od: Deborah D Crane, i wsp.
Wydane: (2014-08-01)

Pharmacological Inhibitors of the NLRP3 Inflammasome
od: Ayesha Zahid, i wsp.
Wydane: (2019-10-01)

COVID-19: lipid disruption is pushing the envelope
od: Garret A. FitzGerald
Wydane: (2022-07-01)

AIM2-inflammasome role in systemic lupus erythematous and rheumatoid arthritis
od: E. E. Uresti-Rivera, i wsp.
Wydane: (2022-09-01)

AIM2 Inflammasome's First Decade of Discovery: Focus on Oral Diseases
od: Lufei Wang, i wsp.
Wydane: (2020-08-01)

ER-trafficking triggers NRF1 ubiquitination to promote its proteolytic activation
od: Claire Chavarria, i wsp.
Wydane: (2023-10-01)

Molecular Mechanism for p202-Mediated Specific Inhibition of AIM2 Inflammasome Activation
od: Qian Yin, i wsp.
Wydane: (2013-07-01)

Assembly mechanism of the inflammasome sensor AIM2 revealed by single molecule analysis
od: Meenakshi Sharma, i wsp.
Wydane: (2023-12-01)

Discovery of an inhibitor of DNA-driven inflammation that preferentially targets the AIM2 inflammasome
od: Jack P. Green, i wsp.
Wydane: (2023-05-01)

Tyrosine Dephosphorylation of ASC Modulates the Activation of the NLRP3 and AIM2 Inflammasomes
od: Bezaleel Mambwe, i wsp.
Wydane: (2019-07-01)

AIM2 inflammasome activation benefits the therapeutic effect of BCG in bladder carcinoma
od: Houhong Zhou, i wsp.
Wydane: (2022-10-01)

The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury
od: Hu, Bo, i wsp.
Wydane: (2018)

Pharmacological intervention of curcumin via the NLRP3 inflammasome in ischemic stroke
od: Xiaoxue Du, i wsp.
Wydane: (2023-10-01)

Cytoplasmic DNA and AIM2 inflammasome in RA: where they come from and where they go?
od: Conghui Xu, i wsp.
Wydane: (2024-10-01)

PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation
od: Min Xie, i wsp.
Wydane: (2016-10-01)

Shikonin Suppresses NLRP3 and AIM2 Inflammasomes by Direct Inhibition of Caspase-1.
od: Jernej Zorman, i wsp.
Wydane: (2016-01-01)

Perfluoroalkyl substance pollutants activate the innate immune system through the AIM2 inflammasome
od: Li-Qiu Wang, i wsp.
Wydane: (2021-05-01)

AIM2 Engages Active but Unprocessed Caspase-1 to Induce Noncanonical Activation of the NLRP3 Inflammasome
od: Larissa D. Cunha, i wsp.
Wydane: (2017-07-01)

Disruption of glycolytic flux is a signal for inflammasome signaling and pyroptotic cell death
od: Laura E Sanman, i wsp.
Wydane: (2016-03-01)

Dual Engagement of the NLRP3 and AIM2 Inflammasomes by Plasmodium-Derived Hemozoin and DNA during Malaria
od: Parisa Kalantari, i wsp.
Wydane: (2014-01-01)

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors
od: Xiaoyan Zhan, i wsp.
Wydane: (2023-01-01)

Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer
od: Gulcin Tezcan, i wsp.
Wydane: (2021-02-01)

The recombinant BCG ΔureC::hly vaccine targets the AIM2 Inflammasome to induce autophagy and inflammation
od: Saiga, H, i wsp.
Wydane: (2014)

The impact of AIM2 inflammasome-induced pyroptosis on acute gouty arthritis and asymptomatic hyperuricemia patients
od: Jiyan Chu, i wsp.
Wydane: (2024-07-01)

A novel role of AIM2 inflammasome-mediated pyroptosis in radiofrequency ablation of hepatocellular carcinoma
od: Feifan He, i wsp.
Wydane: (2024-11-01)

Artemisia Extract Suppresses NLRP3 and AIM2 Inflammasome Activation by Inhibition of ASC Phosphorylation
od: Su-Bin Kwak, i wsp.
Wydane: (2018-01-01)

TUDCA alleviates atherosclerosis by inhibiting AIM2 inflammasome and enhancing cholesterol efflux capacity in macrophage
od: Xuyang Wang, i wsp.
Wydane: (2024-06-01)

Correction: Shikonin Suppresses NLRP3 and AIM2 Inflammasomes by Direct Inhibition of Caspase-1.
od: Jernej Zorman, i wsp.
Wydane: (2016-01-01)

Effects of serum-clot contact time on second-trimester prenatal screening markers and their stability in serum
od: Bujišić Nada
Wydane: (2010-01-01)

Breaking barriers: noncanonical inflammasome executes blood–brain barrier disruption
od: Martin Dichgans, i wsp.
Wydane: (2024-08-01)